Publications
- Günther G, Abu-Hussain N, Keller PM, Guler R, Mukasa SL, Wolmarans K, Thienemann F. To treat or not to treat tuberculosis: clinical decision making in patients with previous pulmonary tuberculosis using 18F-FDG PET/CT. Respiratory Medicine Case Reports. 2023, 46: 101932, 10.1016/j.rmcr.2023.101932
- Guler R, Ozturk M, Sabeel S, Motaung B, Parihar SP, Thienemann F, Brombacher F. Targeting molecular inflammatory pathways in granuloma as host-directed therapies for Tuberculosis. Frontiers in Immunology. 2021, 12: 733853, 10.3389/fimmu.2021.733853
- Sabeel S, Motaung B, Ozturk M, Mukasa S, Kengne AP, Blom D, Sliwa K, Nepolo E, Gunther G, Wilkinson R, Schacht C, Thienemann F, Guler R. Protocol for systematic review and meta-analysis: impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases. BMJ Open. 2020, 10: e039034, 10.1136/bmjopen-2020-039034
- Guler R. From host transcriptomics to statins as host-directed drug therapy for tuberculosis. European Journal of Immunology. 2019, 49 (S3: 17th International Congress of Immunology, 19-23 October 2019, Beijing, China): 1141-1142, 10.1002/eji.201970400
- Hadebe S, Chengalroyen M, Guler R, Nakedi K, Koch A, Makatsa M, Shey M, Parihar SP, Bryson B, Marakalala MJ, Ndlovu H. Intervening along the spectrum of tuberculosis: meeting report from the World TB Day nanosymposium in the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town. Gates Open Research. 2019, 3: 1491, 10.12688/gatesopenres.13035.4
